|
1
|
Koh WJ, Abu-Rustum NR, Bean S, Bradley K,
Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, et al:
Uterine neoplasms, version 1.2018, NCCN clinical practice
guidelines in oncology. J Natl Compr Canc Netw. 16:170–199. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mahecha AM and Wang H: The influence of
vascular endothelial growth factor-A and matrix metalloproteinase-2
and −9 in angiogenesis, metastasis, and prognosis of endometrial
cancer. Onco Targets Ther. 10:4617–4624. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
sstatistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Malik TY, Chishti U, Aziz AB and Sheikh I:
Comparison of risk factors and survival of type 1 and type II
endometrial cancers. Pak J Med Sci. 32:886–890. 2016.PubMed/NCBI
|
|
5
|
Mittica G, Ghisoni E, Giannone G, Aglietta
M, Genta S and Valabrega G: Checkpoint inhibitors in endometrial
cancer: Preclinical rationale and clinical activity. Oncotarget.
8:90532–90544. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fakhar S, Saeed G, Khan AH and Alam AY:
Validity of pipelle endometrial sampling in patients with abnormal
uterine bleeding. Ann Saudi Med. 28:188–191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoshida M: Discovery of HTLV-1, the first
human retrovirus, its unique regulatory mechanisms, and insights
into pathogenesis. Oncogene. 24:5931–5937. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
IARC working group on the evaluation of
carcinogenic risks to humans, . Human immunodeficiency viruses and
human T-cell lymphotropic viruses. Lyon, France, 1–18 June 1996.
IARC Monogr Eval Carcinog Risks Hum. 67:1–424. 1996.PubMed/NCBI
|
|
9
|
Human T-cell lymphotropic viruses, . IARC
Monogr Eval Carcinog Risks Hum. 67:261–390. 1996.PubMed/NCBI
|
|
10
|
de Thé G and Kazanji M: An HTLV–I/II
vaccine: From animal models to clinical trials? J Acquir Immune
Defic Syndr Hum Retrovirol. 13 (Suppl 1):S191–S198. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martín-Dávila P, Fortún J, López-Vélez R,
Norman F, Montes de Oca M, Zamarrón P, González MI, Moreno A,
Pumarola T, Garrido G, et al: Transmission of tropical and
geographically restricted infections during solid-organ
transplantation. Clin Microbiol Rev. 21:60–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hollsberg P and Hafler DA: Seminars in
medicine of the Beth Israel Hospital, Boston. Pathogenesis of
diseases induced by human lymphotropic virus type I infection. New
Eng J Med. 328:1173–1182. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Proietti FA, Carneiro-Proietti AB,
Catalan-Soares BC and Murphy EL: Global epidemiology of HTLV–I
infection and associated diseases. Oncogene. 24:6058–6068. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kannian P and Green PL: Human T
lymphotropic virus type 1 (HTLV-1): Molecular biology and
oncogenesis. Viruses. 2:2037–2077. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamanaka S, Nakayama K, Tamai H, Sakamaki
M and Inokuchi K: Adult T-cell leukemia-lymphoma complicated by
Takotsubo cardiomyopathy and HTLV-1-associated myelopathy after
treatment with the anti-CCR4 antibody mogamulizumab. Rinsho
Ketsueki. 58:309–314. 2017.(In Japanese). PubMed/NCBI
|
|
16
|
Tanaka T, Hirata T, Parrott G,
Higashiarakawa M, Kinjo T, Kinjo T, Hokama A and Fujita J:
Relationship among strongyloides stercoralis infection, human
T-cell lymphotropic virus type 1 infection, and cancer: A 24-year
cohort inpatient study in Okinawa, Japan. Am J Trop Med Hyg.
94:365–370. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Howard C: The Interplay between HTLV-1
Viral Factors, Tax and HBZ, During T-cell Transformation. The Ohio
State University. 2016.
|
|
18
|
Vicario M, Mattiolo A, Montini B, Piano
MA, Cavallari I, Amadori A, Chieco-Bianchi L and Calabrò ML: A
preclinical model for the atll lymphoma subtype with insights into
the role of microenvironment in HTLV-1-mediated lymphomagenesis.
Front Microbiol. 9:12152018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen JL, Limnander A and Rothman PB: Pim-1
and Pim-2 kinases are required for efficient pre-B-cell
transformation by v-Abl oncogene. Blood. 111:1677–1685. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo G, Qiu X, Wang S, Chen Y, Rothman PB,
Wang Z, Chen Y, Wang G and Chen JL: Oncogenic E17K mutation in the
pleckstrin homology domain of AKT1 promotes v-Abl-mediated
pre-B-cell transformation and survival of Pim-deficient cells.
Oncogene. 29:3845–3853. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang J, Wang J, Chen K, Guo G, Xi R,
Rothman PB, Whitten D, Zhang L, Huang S and Chen JL: eIF4B
phosphorylation by pim kinases plays a critical role in cellular
transformation by Abl oncogenes. Cancer Res. 73:4898–4908. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Love M, Anders S and Huber W: Differential
analysis of count data - the DESeq2 package. Genome Biol.
15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gentleman RC, Carey VJ, Bates DM, Bolstad
B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al:
Bioconductor: Open software development for computational biology
and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Therneau TM: Survival analysis [R package
survival version 2.41–3]. Technometrics. 46:111–112. 2015.
|
|
25
|
Wang L, Cao C, Ma Q, Zeng Q, Wang H, Cheng
Z, Zhu G, Qi J, Ma H, Nian H and Wang Y: RNA-seq analyses of
multiple meristems of soybean: Novel and alternative transcripts,
evolutionary and functional implications. BMC Plant Biol.
14:1692014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arisawa K, Soda M, Akahoshi M, Fujiwara S,
Uemura H, Hiyoshi M, Takeda H, Kashino W and Suyama A: Human T-cell
lymphotropic virus type-1 infection and risk of cancer: 15.4 year
longitudinal study among atomic bomb survivors in Nagasaki, Japan.
Cancer Sci. 97:535–539. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kozuru M, Uike N, Muta K, Goto T, Suehiro
Y and Nagano M: High occurrence of primary malignant neoplasms in
patients with adult T-cell leukemia/lymphoma, their siblings, and
their mothers. Cancer. 78:1119–1124. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Beltran BE, Quiñones P, Morales D, Revilla
JC, Alva JC and Castillo JJ: Diffuse large B-cell lymphoma in human
T-lymphotropic virus type 1 carriers. Leuk Res Treatment.
2012:2623632012.PubMed/NCBI
|
